A Phase Ib/IIa Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Oral Ecnoglutide Tablets in Chinese Participants With Overweight or Obesity

Abroad (travel likely)RecruitingPHASE1, PHASE2

Conditions

Overweight and/or Obesity · Weight Management

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations
  • China-Japan Friendship Hospital, Beijing, Beijing Municipality, China

Study leads
  • Jintong Li, Dr

    Principal Investigator

    China-Japan Friendship Hospital